International Stem Cell (ISCO) Enterprise Value (2016 - 2025)
Historic Enterprise Value for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to -$966000.0.
- International Stem Cell's Enterprise Value rose 2609.03% to -$966000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$966000.0, marking a year-over-year increase of 2609.03%. This contributed to the annual value of -$1.2 million for FY2024, which is 2254.41% up from last year.
- As of Q3 2025, International Stem Cell's Enterprise Value stood at -$966000.0, which was up 2609.03% from -$920000.0 recorded in Q2 2025.
- In the past 5 years, International Stem Cell's Enterprise Value registered a high of -$171000.0 during Q4 2021, and its lowest value of -$1.6 million during Q4 2023.
- For the 5-year period, International Stem Cell's Enterprise Value averaged around -$991000.0, with its median value being -$966000.0 (2025).
- In the last 5 years, International Stem Cell's Enterprise Value soared by 7518.14% in 2021 and then plummeted by 33391.81% in 2022.
- International Stem Cell's Enterprise Value (Quarter) stood at -$171000.0 in 2021, then plummeted by 333.92% to -$742000.0 in 2022, then tumbled by 114.02% to -$1.6 million in 2023, then grew by 22.54% to -$1.2 million in 2024, then grew by 21.46% to -$966000.0 in 2025.
- Its Enterprise Value was -$966000.0 in Q3 2025, compared to -$920000.0 in Q2 2025 and -$1.5 million in Q1 2025.